Skip to main content
main-content

Insulin glargine

News

02-20-2019 | Insulin degludec/Liraglutide | News

Support for add-on IDegLira in SGLT2 inhibitor-treated type 2 diabetes

Findings from the DUAL IX trial suggest that the addition of insulin degludec/liraglutide to SGLT2 inhibitor therapy results in better glycemic control than add-on insulin glargine among insulin-naïve patients with uncontrolled type 2 diabetes.

12-19-2018 | Insulin degludec | Highlight | News

Real-world data show benefits of insulin degludec vs glargine in type 2 diabetes

Insulin-naive adults with type 2 diabetes derive greater benefit from treatment with insulin degludec than from insulin glargine 300 units/mL, results from the US clinical practice-based CONFIRM study show.

11-27-2018 | Sitagliptin | News

Sitagliptin continuation benefits insulin initiators

Continuation of sitagliptin during initiation of insulin glargine therapy results in a greater reduction in glycated hemoglobin, without increased hypoglycemia, than discontinuation in patients with type 2 diabetes, study data show.

Read more

Related topics

Superior

Related

Opinion

11-08-2017 | Long-acting insulins | Editorial | Article

Longer-acting basal insulin analogs: What, how, why, when, and who?

Advisory Board member and pharmacist, Josh Neumiller, presents a practical guide to support clinical decision-making in the initiation and titration of U-300 insulin glargine and insulin degludec.

Journal articles and book chapters

06-21-2018 | Hypoglycemia | Review | Article

Hypoglycemia among patients with type 2 diabetes: Epidemiology, risk factors, and prevention strategies

Silbert R et al. Curr Diab Rep 2018; 18: 53. doi: 10.1007/s11892-018-1018-0

06-16-2018 | Medications | Review | Article

Availability and affordability of essential medicines: Implications for global diabetes treatment

Beran D et al. Curr Diab Rep 2018; 18: 48. doi: 10.1007/s11892-018-1019-z

05-03-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: The new insulins

Toledano Y, Hadar E, Hod M. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.035

Case reports

image credits